Alembic Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

5,874.06

5,149.00

4,996.61

5,051.44

4,132.55

Operating profit

998.52

664.33

1,054.46

1,572.23

1,202.90

Interest

54.47

49.00

16.67

12.77

25.19

Gross profit

975.37

618.88

1,087.77

1,569.19

1,312.46

EPS (Rs)

33.91

17.64

40.39

59.80

51.43

Other income

31.32

3.55

49.98

9.73

134.75

Stock adjustment

-52.36

72.84

18.41

-157.13

-176.50

Raw material

1,403.01

1,250.08

1,111.75

1,175.71

978.13

Power and fuel

-

-

-

-

-

Employee expenses

1,335.91

1,094.82

1,028.18

948.27

806.37

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

2,188.98

2,066.93

1,783.80

1,512.36

1,321.65

Provisions made

-

-

-

-

-

Depreciation

271.14

272.95

179.31

152.60

135.67

Taxation

37.75

-0.80

114.45

241.20

197.39

Net profit / loss

666.48

346.73

794.00

1,175.39

969.40

Extra ordinary item

-

-

-

-

-10.00

Prior year adjustments

-

-

-

-

-

Equity capital

39.31

39.31

39.31

39.31

37.70

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

17.00

12.90

21.10

31.12

29.11

GPM (%)

16.52

12.01

21.55

31.00

30.76

NPM (%)

11.29

6.73

15.73

23.22

22.72